|
|
|
Volumn 13, Issue 1, 2002, Pages 14-20
|
|
Preparing for the introduction of new technologies: who is going to pay for them?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
RAPAMYCIN;
ANIMAL;
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
BRACHYTHERAPY;
CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
ECONOMICS;
HUMAN;
INSTRUMENTATION;
MEDICAL TECHNOLOGY;
REIMBURSEMENT;
RESTENOSIS;
STENT;
UNITED STATES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BIOMEDICAL TECHNOLOGY;
BRACHYTHERAPY;
CLINICAL TRIALS;
CORONARY ARTERIOSCLEROSIS;
CORONARY RESTENOSIS;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
SIROLIMUS;
STENTS;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
UNITED STATES;
|
|
EID: 0036371976
PISSN: 10535330
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
